19834-77-6Relevant academic research and scientific papers
PYRANOPYRAZOLE AND PYRAZOLOPYRIDINE IMMUNOMODULATORS FOR TREATMENT OF AUTOIMMUNE DISEASES
-
Paragraph 0169; 0170, (2019/06/17)
Pyranoyrazoles and pyrazolopyridines of formula I or formula II are disclosed: (I), (II) These compounds inhibit Coagulation Factor Xlla in the presence of thrombin and other coagulation factors. They are useful to treat autoimmune diseases.
PHOTOREACTIONS OF QUININE IN AQUEOUS CITRIC ACID SOLUTION. PART 2. SOME END-PRODUCTS
Laurie, W. A.,McHale, D.,Saag, K.,Sheridan, J. B.
, p. 5905 - 5910 (2007/10/02)
A novel spiro-compound derived from 2',4'-bis-(1,3-dicarboxy-2-hydroxyprop-2-yl)-1',4'-dihydroquinine has been identified as a major end-product of the irradiation of quinine in aqueous citric acid solution. 7'-(1,3-Dicarboxy-2-hydroxyprop-2-yl)deoxyquinine and products arising from the cleavage of quinine at C-9 were also detected in the reaction mixture.
